I was amazed recently at the level of response to a small post on my "other" blog on the subject of Twitter.
I was amazed recently at the level of response to a small post on my "other" blog on the subject of Twitter. [See [www.intouchsolutionsdigital.blogspot.com] Although most people have probably heard of Twitter, its number of active users remains small compared to social media giants such as Facebook.
Personally, I have been playing around with Twitter lately to get to know it a little better. I'm still not convinced it is the miracle marketing medium some think it is. I do see the attraction and the possibilities, done well, for marketing big consumer brands. But mostly I see it as a fun time waster. And I find it can be extremely distracting and addictive as well. Personally, I experience Twitter in fits and starts.
Do I ever think Pharma will enthusiastically adopt Twitter? It's possible. But it would have to be the right product, the right message and the right person. So I put the question out there on my blog asking if anyone knew of any pharmas that were currently on Twitter. The response I recieved was the most of any blog post I had posted to date!
In the spirit of sharing, here's a list of pharma-related Tweeps that came out of the wordwork, including several pharma companies:
twitter.com/bradatpharma
twitter.com/boehringer
twitter.com/novartis
twitter.com/cafepharma
twitter.com/craigmurray
twitter.com/arthur_alston
I'm on Twitter, too, but my posts are not always pharma-related. You can find me at @wendyblackburn
Please let me know of any further pharma-related Tweeps of which you are aware. And if you, too, are on Twitter, maybe I will see you there...
blog comments powered by DisqusOften criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Jan Stojaspal explores the role of value-based pricing in gaining market access
Andrew Tolve explores how digital health coaching is helping the healthcare industry provide cost-effective services that boost adherence
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs